ESSA Pharma 2021 Jefferies Virtual Healthcare Conference

ESSA Pharma presents its corporate overview and development pipeline at the 2021 Jefferies Virtual Healthcare Conference. The company focuses on novel N-terminal domain inhibitors of the androgen receptor for prostate cancer and other hormone-driven cancers, with lead program EPI-7386 in Phase 1 clinical development.